Literature DB >> 20597918

CHEK2, breast cancer, and the understanding of clinical utility.

M Robson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20597918     DOI： 10.1111/j.1399-0004.2010.01444.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN： 0009-9163            Impact factor:   4.438


× No keyword cloud information.
  3 in total

Review 1.  Counselling framework for moderate-penetrance cancer-susceptibility mutations.

Authors:  Nadine Tung; Susan M Domchek; Zsofia Stadler; Katherine L Nathanson; Fergus Couch; Judy E Garber; Kenneth Offit; Mark E Robson
Journal:  Nat Rev Clin Oncol       Date:  2016-06-14       Impact factor: 66.675

Review 2.  MicroRNAs, Hypoxia and the Stem-Like State as Contributors to Cancer Aggressiveness.

Authors:  Lucy Wanjiku Macharia; Caroline Muriithi Wanjiru; Marianne Wanjiru Mureithi; Claudia Maria Pereira; Valéria Pereira Ferrer; Vivaldo Moura-Neto
Journal:  Front Genet       Date:  2019-02-20       Impact factor: 4.599

3.  The genetics of breast cancer: risk factors for disease.

Authors:  Andrew Collins; Ioannis Politopoulos
Journal:  Appl Clin Genet       Date:  2011-01-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.